Trademark: 88369774
Status Date
Monday, March 20, 2023
Filing Date
Wednesday, April 3, 2019
Published for Opposition
Tuesday, December 17, 2019
Abandoned Date
Monday, March 20, 2023
9 Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable computer software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; downloadable computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
42 Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; providing a website for electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes
Mar 20, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 20, 2023
Abandonment - No Use Statement Filed
Aug 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2022
Sou Extension 5 Granted
Jul 27, 2022
Sou Extension 5 Filed
Aug 8, 2022
Case Assigned To Intent To Use Paralegal
Jul 27, 2022
Sou Teas Extension Received
Jan 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2022
Sou Extension 4 Granted
Jan 25, 2022
Sou Extension 4 Filed
Jan 25, 2022
Sou Teas Extension Received
Jul 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2021
Sou Extension 3 Granted
Jul 13, 2021
Sou Extension 3 Filed
Jul 13, 2021
Sou Teas Extension Received
Jan 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 28, 2021
Sou Extension 2 Granted
Jan 28, 2021
Sou Extension 2 Filed
Jan 28, 2021
Sou Teas Extension Received
Oct 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 19, 2020
Teas Change Of Correspondence Received
Oct 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 19, 2020
Teas Change Of Owner Address Received
Aug 13, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2020
Sou Extension 1 Granted
Aug 11, 2020
Sou Extension 1 Filed
Aug 11, 2020
Sou Teas Extension Received
Feb 11, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 17, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 17, 2019
Published For Opposition
Nov 27, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 27, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 27, 2019
Notification Of Notice Of Publication E-Mailed
Nov 11, 2019
Approved For Pub - Principal Register
Oct 11, 2019
Teas/Email Correspondence Entered
Oct 11, 2019
Correspondence Received In Law Office
Oct 10, 2019
Assigned To Lie
Oct 4, 2019
Teas Response To Office Action Received
Oct 2, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 2, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2019
Notification Of Non-Final Action E-Mailed
Jul 8, 2019
Non-Final Action E-Mailed
Jul 8, 2019
Non-Final Action Written
Jun 13, 2019
Assigned To Examiner
Apr 22, 2019
New Application Office Supplied Data Entered
Apr 6, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
